tradingkey.logo
搜索

Haemonetics Corp

HAE
添加自选
75.020USD
-0.100-0.13%
收盘 06/30, 16:00美东报价延迟15分钟
3.41B总市值
36.37市盈率 TTM

Haemonetics Corp

75.020
-0.100-0.13%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-0.13%

5天

+3.08%

1月

+10.63%

6月

-6.40%

今年开始到现在

-6.40%

1年

+0.55%

关键数据
74.580今开
75.780最高
562.61K成交量
36.37市盈率 TTM
14.23市盈率动
--股息TTM
1.24%换手率
75.120昨收
72.340最低
19.02M成交额
20.25市盈率静
4.26市净率
0.00%股息率 TTM
4.02%ROA
87.32052周最高
0.68量比
167.68M净利润
45.25M总股本
2.0625每股收益TTM
0.55Beta
12.03%ROE
47.31552周最低
4.58%振幅
54.22%毛利率
3.41B总市值
4.26回报/风险
2.76%风险率

TradingKey Haemonetics Corp股票评分

单位: USD 更新时间: 2026-06-30

操作建议

Haemonetics Corp当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名34/204位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价87.78。中期看,股价处于上升通道。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Haemonetics Corp评分

相关信息

行业排名
34 / 204
全市场排名
103 / 4569
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看好

Haemonetics Corp亮点

亮点风险
Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.
估值高估
公司最新PE估值36.36,处于3年历史高位
机构加仓
最新机构持股58.91M股,环比增加1.11%
约翰·胡斯曼持仓
明星投资者约翰·胡斯曼持仓,最新持仓市值8.81K
活跃度增加
近期活跃度增加,过去20天平均换手率0.33

分析师目标

根据 11 位分析师
买入
评级
87.778
目标均价
+16.85%
涨幅空间

Haemonetics Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Haemonetics Corp简介

Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.
公司代码HAE
公司Haemonetics Corp
CEOSimon (Christopher A)
网址https://www.haemonetics.com

常见问题

Haemonetics Corp(HAE)的当前股价是多少?

Haemonetics Corp(HAE)的当前股价是 75.02。

Haemonetics Corp的股票代码是什么?

Haemonetics Corp的股票代码是HAE。

Haemonetics Corp股票的52周最高点是多少?

Haemonetics Corp股票的52周最高点是87.32。

Haemonetics Corp股票的52周最低点是多少?

Haemonetics Corp股票的52周最低点是47.31。

Haemonetics Corp的市值是多少?

Haemonetics Corp的市值是3.39B。

现在Haemonetics Corp(HAE)的股票是买入、持有还是卖出?

根据分析师评级,Haemonetics Corp(HAE)的总体评级为买入,目标价格为87.78。

Haemonetics Corp(HAE)股票的每股收益(EPS TTM)是多少

Haemonetics Corp(HAE)股票的每股收益(EPS TTM)是2.06。